Breast Cancer Research and Treatment

, Volume 132, Issue 2, pp 741–746

Genetic variants at chromosome 9p21, 10p15 and 10q22 and breast cancer susceptibility in a Chinese population

  • Jiaping Chen
  • Yue Jiang
  • Xiaoan Liu
  • Zhenzhen Qin
  • Juncheng Dai
  • Guangfu Jin
  • Hongxia Ma
  • Shui Wang
  • Xinru Wang
  • Zhibin Hu
  • Hongbing Shen
Epidemiology

DOI: 10.1007/s10549-011-1927-y

Cite this article as:
Chen, J., Jiang, Y., Liu, X. et al. Breast Cancer Res Treat (2012) 132: 741. doi:10.1007/s10549-011-1927-y

Abstract

A recent genome-wide association study (GWAS) has identified a new subset of breast cancer susceptibility loci on chromosomes 9, 10, and 11 in populations of European descent. However, because of the genetic heterogeneity, the role of these loci in non-European descent populations is still unclear. To evaluate the relationships between genetic variants in these regions identified by GWAS and breast cancer risk in Chinese women, we genotyped four common SNPs at 9p21(rs1011970 and rs10757278), 10p15 (rs2380205), and 10q22 (rs1250009) in a two-stage case–control study with a total of 1792 breast cancer cases and 1,867 controls. We found that rs1250009 at 10q22 was consistently associated with risk of breast cancer in stage 1 and stage 2, with a per-allele OR of 1.13 (95% CI 1.02–1.25) after two stages combined (P = 0.023). However, no significant associations were observed between the other three SNPs and breast cancer risk. Our results suggest that the genetic variants at 10q22 may play an important role in breast cancer development in Chinese women, and rs1250009 may be a candidate marker for breast cancer susceptibility.

Keywords

Breast cancerGenome-wide association study10q22PolymorphismsSusceptibility

Supplementary material

10549_2011_1927_MOESM1_ESM.doc (42 kb)
Supplementary material 1 (DOC 42 kb)

Copyright information

© Springer Science+Business Media, LLC. 2011

Authors and Affiliations

  • Jiaping Chen
    • 1
    • 3
  • Yue Jiang
    • 1
    • 2
    • 3
  • Xiaoan Liu
    • 4
  • Zhenzhen Qin
    • 1
  • Juncheng Dai
    • 1
  • Guangfu Jin
    • 1
    • 2
    • 3
  • Hongxia Ma
    • 1
    • 2
  • Shui Wang
    • 4
  • Xinru Wang
    • 1
    • 2
  • Zhibin Hu
    • 1
    • 2
    • 3
  • Hongbing Shen
    • 1
    • 2
    • 3
  1. 1.MOE Key Laboratory of Modern Toxicology, School of Public HealthNanjing Medical UniversityNanjingChina
  2. 2.State Key Laboratory of Reproductive Medicine, Institute of ToxicologyNanjing Medical UniversityNanjingChina
  3. 3.Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer CenterNanjing Medical UniversityNanjingChina
  4. 4.Department of General SurgeryThe First Affiliated Hospital of Nanjing Medical UniversityNanjingChina